七花在滋补食材药材行业中的票数：201
【七花是哪个国家的品牌？】
外推网助力七花品牌出海！通过在本页面挂载七花品牌的产品链接和联系邮箱，可以提高七花产品曝光！跨境电商爆单神器，目前只要100元/年哦~
云南白药集团文山七花有限责任公司，成立于1996年12月19日，公司前身为始建于1959年6月的文山州制药厂，是文山地区的骨干制药企业。
厂区占地面积15563.38平方米，其中绿化面积6000多平方米。厂房依山而建，环境优美，气候宜人，是生产药品的理想之地。2010年2月9日，经过二次改制及股权结构调整后的公司已成为云南白药集团股份有限公司的全资子公司。
公司一贯坚持 以人为本、科技兴企 的发展原则，现有员工100余人，其中专业技术人员60余人，占职工总数的50%以上。公司于2002年通过了国家药品GMP认证，目前获认证剂型分别为胶囊剂、口服液、片剂、合剂、散剂、颗粒剂、原料药（三七总皂苷）。公司生产的七灵宝胶囊及“七花”牌气血康口服液、三七蜜精口服液、气血康胶囊、血塞通胶囊、三七胶囊、三七片、复方丹参片、生三七粉、熟三七粉、
三七总皂苷(原料药)等三七系列产品已行销全国。现常年生产的品种有21种。2009年5月，公司新产品气血康片获得生产批文。
未来，公司将以天然药物和现代中药开发、生产为发展方向，在三七有效成分的提取、药品和三七保健品等方面进行深度开发。并在云南白药集团股份有限公司的支持下，对现有产品进行调整（质量及包装）提升，还将利用集团的销售平台扩大销售规模，同时建设三七原料物流平台并努力打造品牌保健礼品。为三七产业发展、为推动中药现代化、国际化做出应有的贡献。
英文翻译：Wenshan seven flowers Co., Ltd. of Yunnan Baiyao group was founded on December 19, 1996. The predecessor of the company is Wenshan pharmaceutical factory, which was founded in June 1959. It is a backbone pharmaceutical enterprise in Wenshan area. The plant covers an area of 15563.38 square meters, including more than 6000 square meters of green area. The factory is built on the mountain, with beautiful environment and pleasant climate. It is an ideal place to produce medicine. On February 9, 2010, after the secondary restructuring and equity structure adjustment, the company has become a wholly-owned subsidiary of Yunnan Baiyao Group Co., Ltd. The company has always adhered to the development principle of people-oriented, science and technology, and now has more than 100 employees, including more than 60 professional and technical personnel, accounting for more than 50% of the total number of employees. In 2002, the company passed the national GMP certification. At present, the certified dosage forms are capsule, oral liquid, tablet, mixture, powder, granule and API (total saponins of Panax notoginseng). Qilingbao capsule and Qihua brand qiqiqikang oral liquid, sanqimijing oral liquid, qiqikang capsule, Xuesaitong capsule, Sanqi capsule, Sanqi tablet, compound danshen tablet, raw Sanqi powder, cooked Sanqi powder, total saponins of Sanqi (API) and other Sanqi series products produced by the company have been sold all over the country. At present, there are 21 varieties produced all year round. In May 2009, the company's new product qiankang tablet was approved for production. In the future, the company will take the development and production of natural medicine and modern Chinese medicine as the development direction, and carry out in-depth development in the extraction of active ingredients, drugs and health products of Panax notoginseng. With the support of Yunnan Baiyao Group Co., Ltd., we will adjust the existing products (quality and packaging), expand the sales scale by using the group's sales platform, build the 37 raw material logistics platform and strive to create brand health gifts. To make due contribution to the development of the industry of Panax notoginseng, the modernization and internationalization of traditional Chinese medicine.
本文链接： https://www.waitui.com/brand/3bcc494a7.html 联系电话：请联系客服添加
浙公网安备 33011802001999号
